Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Timolol. Canadian multicenter study

R P LeBlanc, G Krip

    Ophthalmology
    |March 1, 1981
    PubMed
    Summary
    This summary is machine-generated.

    Short-term use of timolol maleate effectively lowers intraocular pressure in a large patient group. The study found excellent pressure response with minimal adverse reactions reported.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    Central corneal thickness and progression of the visual field and optic disc in glaucoma.

    The British journal of ophthalmology·2005
    Same author

    Agreement among clinicians in the recognition of patterns of optic disk damage in glaucoma.

    American journal of ophthalmology·2001
    Same author

    Scanning laser polarimetry in a selected group of patients with glaucoma and normal controls.

    American journal of ophthalmology·2001
    Same author

    Optic disc and visual field changes in a prospective longitudinal study of patients with glaucoma: comparison of scanning laser tomography with conventional perimetry and optic disc photography.

    Archives of ophthalmology (Chicago, Ill. : 1960)·2001
    Same author

    Comparison of conventional and pattern discrimination perimetry in a prospective study of glaucoma patients.

    Investigative ophthalmology & visual science·2000
    Same author

    Lorenzetti Lecture: leadership: it's our turn.

    Canadian journal of ophthalmology. Journal canadien d'ophtalmologie·2000
    Same journal

    Metastasis of Nasopharyngeal Squamous Cell Carcinoma to the Angle.

    Ophthalmology·2026
    Same journal

    Endocrine Mucin-Producing Sweat Gland Carcinoma of Eyelid.

    Ophthalmology·2026
    Same journal

    Multimodal Imaging of Optic Nerve Invasion in Unilateral Retinoblastoma.

    Ophthalmology·2026
    Same journal

    Avacincaptad Pegol Slows Progressive Ellipsoid Zone Degradation/Loss in Eyes With Geographic Atrophy.

    Ophthalmology·2026
    Same journal

    Access to Intravitreal Anti-VEGF Drugs in Persons with Medicare Advantage Compared with Medicare Fee-For-Service.

    Ophthalmology·2026
    Same journal

    Re: Dones et al.: Emergency department use of ocular point-of-care ultrasound and its utility in diagnosis at a tertiary academic medical center (Ophthalmology. 2026;133:720-727).

    Ophthalmology·2026
    See all related articles

    Area of Science:

    • Ophthalmology
    • Clinical Pharmacology

    Background:

    • Elevated intraocular pressure (IOP) is a significant risk factor for glaucoma.
    • Timolol maleate is a commonly prescribed beta-blocker for IOP management.

    Purpose of the Study:

    • To evaluate the short-term efficacy and safety of timolol maleate in a large patient cohort.
    • To assess the intraocular pressure response and patient-reported outcomes.

    Main Methods:

    • A collaborative study involving 39 investigators.
    • Inclusion of 418 patients receiving short-term timolol maleate treatment.
    • Statistical analysis of IOP response using random sampling.

    Main Results:

    • Excellent intraocular pressure response observed across the patient group.

    Related Experiment Videos

  • Monitoring of patient complaints revealed interesting findings.
  • A very low incidence of adverse reactions was reported.

    • Conclusions:

    • Short-term administration of timolol maleate demonstrates high efficacy in reducing intraocular pressure.
    • The medication is well-tolerated, with a favorable safety profile in this patient population.